A detailed history of Tredje Ap Fonden transactions in Albemarle Corp stock. As of the latest transaction made, Tredje Ap Fonden holds 145,356 shares of ALB stock, worth $15.7 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
145,356
Previous 145,356 -0.0%
Holding current value
$15.7 Million
Previous $13.9 Million 0.85%
% of portfolio
0.13%
Previous 0.14%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$92.77 - $135.46 $47,034 - $68,678
-507 Reduced 0.35%
145,356 $13.9 Million
Q1 2024

May 13, 2024

SELL
$108.73 - $146.89 $447,750 - $604,893
-4,118 Reduced 2.75%
145,863 $19.2 Million
Q4 2023

Feb 12, 2024

BUY
$113.26 - $170.8 $5.5 Million - $8.29 Million
48,517 Added 47.82%
149,981 $21.7 Million
Q3 2023

Nov 09, 2023

BUY
$162.63 - $243.44 $107,335 - $160,670
660 Added 0.65%
101,464 $17.3 Million
Q2 2023

Aug 11, 2023

BUY
$172.91 - $232.22 $1.58 Million - $2.12 Million
9,120 Added 9.95%
100,804 $22.5 Million
Q1 2023

May 10, 2023

BUY
$208.49 - $290.15 $2.08 Million - $2.89 Million
9,962 Added 12.19%
91,684 $20.3 Million
Q4 2022

Feb 10, 2023

BUY
$214.02 - $325.38 $1.87 Million - $2.84 Million
8,739 Added 11.97%
81,722 $17.7 Million
Q3 2022

Nov 10, 2022

BUY
$195.82 - $307.05 $13.3 Million - $20.9 Million
68,111 Added 1398.01%
72,983 $19.3 Million
Q4 2021

Feb 10, 2022

BUY
$214.16 - $283.8 $1.04 Million - $1.38 Million
4,872 New
4,872 $1.14 Million
Q2 2018

Aug 09, 2018

SELL
$88.96 - $104.92 $247,308 - $291,677
-2,780 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$89.56 - $137.45 $181,806 - $279,023
-2,030 Reduced 42.2%
2,780 $259,000
Q4 2017

Feb 12, 2018

SELL
$127.48 - $144.58 $275,356 - $312,292
-2,160 Reduced 30.99%
4,810 $617,000
Q3 2017

Nov 13, 2017

BUY
$109.36 - $136.31 $762,239 - $950,080
6,970
6,970 $952,000

Others Institutions Holding ALB

About ALBEMARLE CORP


  • Ticker ALB
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 117,129,000
  • Market Cap $12.6B
  • Description
  • Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...
More about ALB
Track This Portfolio

Track Tredje Ap Fonden Portfolio

Follow Tredje Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.